Khaberni - Japanese scientists are close to introducing a new treatment that represents a quantum leap in the world of veterinary medicine that could change the fate of millions of cats around the world, after it was shown that more than 40% of cats over 10 years old suffer from incurable chronic kidney failure until now.
The French television station "France.Info" mentioned that chronic kidney diseases in cats are intractable diseases that cannot currently be stopped from progressing, as dealing with them is limited to slowing down the deterioration of the condition without the ability to completely cure it. However, a new scientific discovery from Japan could drastically change this equation.
The Japanese researcher Toru Miyazaki from the "AIM" Institute of Medicine in Tokyo announced that he has officially applied to the Ministry of Agriculture for a license for a new drug capable of treating kidney failure in cats.
This treatment is expected to make an unprecedented breakthrough in prolonging the lives of cats, possibly up to 30 years.
The roots of this discovery go back to a blood protein known as "AIM," which is responsible for eliminating accumulated waste in the body.
However, this protein does not work efficiently in cats, leading to the accumulation of waste and gradual blockage in the kidneys and deterioration of their functions. From here, Miyazaki developed a treatment that works in a way similar to “unclogging blocked pipes,” which helps to restore kidney function naturally.
Although the treatment is still under study and evaluation, the "AIM" protein itself was discovered more than twenty years ago by the same researcher, which enhances the credibility of the scientific project.
After a series of clinical trials, a study was published in a scientific veterinary medicine journal showing striking results, where the survival rate of cats that received the treatment was between 80 and 83%, compared to only 20% in cases that did not receive any treatment.
Following these encouraging results, researcher Toru Miyazaki confirmed that his primary goal is to change the reality of this disease, alleviating the health and financial burden on the animals and their owners, indicating that this development could pave the way for longer years of cohabitation between humans and their cats.
In light of these promising results, the veterinary world is awaiting the official approval of this treatment, which could represent a real revolution in the field of pet medicine.
